Abstract
The purpose of the paper is to gain insight into the possible impact of the Medical Evaluation Program on driving performance of two subgroups of the medically impaired driving population that are known to the Division of Motor Vehicles. These subgroups are patients with heart disease or epilepsy. Recommen-dations for further research are presented.